Please Wait
Applying Filters...
menu
    • menu
    Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

    Data Compilation
    #PharmaFlow

    Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

    Stock Recap
    #PipelineProspector

    Menu

    CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 197Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    29/11/2025 Antibioticos do Brasil Ltda
    Brazil
    		 BC World Pharmaceutical Co., Ltd. 20180208-84-D-143-10(1) Cefepime hydrochloride hydrate 2018-05-29 Antibiotics do Brasil Ltda.@[Antibiotics Manufacturing Company] ACS Dobfar SpA Brazil Rodovia Professor Zeferio Vaz, Km 135, SP-332-Itapavussu-13.150-000 Comopolis, SP, Brazil@[Viale Addetta 2a/12 20067 Tribiano, MI/ Italy
    29/11/2025 Antibioticos do Brasil Ltda
    Brazil
    		 Youngjin Pharmaceutical Co., Ltd. 20180208-84-D-143-10(2) Cefepime hydrochloride hydrate 2020-07-02 Antibiotics do Brasil Ltda.@ACS Dobfar SpA Brazil Rodovia Professor Zeferio Vaz, Km 135, SP-332-Itapavussu-13.150-000 Comopolis, SP, Brazil@Viale Addetta 2a/12 20067 Tribiano, MI/ Italy